Connect with us

IT Industry

Check Point Research Reveals Modern Cameras’ Connectivity to Wi-Fi Make Them Vulnerable to Ransomware and Malware

GlobeNewswire

Published

on

Reading Time: 2 minutes

Critical vulnerabilities identified can result in photos held ransom for money by attackers

SAN CARLOS, Calif., Aug. 11, 2019 (GLOBE NEWSWIRE) — Check Point Research, the Threat Intelligence arm of Check Point® Software Technologies Ltd. (NASDAQ: CHKP), a leading provider of cyber security solutions globally, revealed that through the USB and connections to WiFi networks, today’s modern cameras are vulnerable to ransomware and malware attacks.

Since modern cameras no longer use film to capture and reproduce images, the International Imaging Industry Association devised a standardised protocol known as Picture Transfer Protocol (PTP) to transfer digital images from camera to PC. Initially focused on image transfer, this protocol has evolved to include dozens of different commands that support anything from taking a live picture to upgrading the camera’s firmware.

Check Point Research aimed to access the cameras and exploit vulnerabilities in the protocol to infect the camera. For the research, Check Point used Canon’s EOS 80D DSLR camera which supports both USB and WiFi, and critical vulnerabilities in the PTP were found. Given that the protocol is standardized and embedded in other camera brands, Check Point believes similar vulnerabilities can be found in cameras from other vendors as well.

“Any ‘smart’ device, including the DSLR camera, is susceptible to attacks,” says Eyal Itkin, Security Researcher, Check Point Software Technologies. “Cameras are no longer just connected to the USB, but to the WiFi network and its surrounding environment. This makes them more vulnerable to threats as attackers can inject ransomware into both the camera and PC it is connected to. The photos could end up being held hostage until the user pays the ransom for them to be released.”

Here are some things camera owners can do to avoid being infected:

  1. Make sure your camera is using the latest firmware version, and install a patch if available.
  2. Turn off the camera’s WiFi when not in use.
  3. When using WiFi, prefer using the camera as the WiFi access point, rather than connecting your camera to a public WiFi network.

Check Point Research informed Canon about the vulnerabilities and the companies worked together to patch them. Canon published the patch as part of an official security advisory in English and Japanese.

For more information about how the research was carried out, visit: https://research.checkpoint.com/say-cheese-ransomware-ing-a-dslr-camera or https://youtu.be/75fVog7MKgg

Follow Check Point Research via:
Blog: https://research.checkpoint.com/
Twitter: https://twitter.com/_cpresearch_

About Check Point Research
Check Point Research provides leading cyber threat intelligence to Check Point Software customers and the greater intelligence community. The research team collects and analyzes global cyber-attack data stored on ThreatCloud to keep hackers at bay, while ensuring all Check Point products are updated with the latest protections. The research team consists of over 100 analysts and researchers cooperating with other security vendors, law enforcement and various CERTs.

About Check Point Software Technologies Ltd.
Check Point Software Technologies Ltd. (www.checkpoint.com) is a leading provider of cyber security solutions to governments and corporate enterprises globally.  Check Point’s solutions protect customers from 5th generation cyber-attacks with an industry leading catch rate of malware, ransomware and advanced targeted threats. Check Point offers a multilevel security architecture, “Infinity Total Protection with Gen V advanced threat prevention”, this combined product architecture defends an enterprises’ cloud, network and mobile devices. Check Point provides the most comprehensive and intuitive one point of control security management system. Check Point protects over 100,000 organizations of all sizes.

MEDIA CONTACT:                   
Jacinta Paul                            
Check Point Software Technologies
+65 9430 4020                         
press@us.checkpoint.com  

INVESTOR CONTACT:   
Kip E. Meintzer

Check Point Software Technologies
+1 650.628.2040
 ir@us.checkpoint.com

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

IT Industry

Next-Generation Sequencing (NGS) Market 2019 Global Insights Type of Sequencing, Product Type, End User, Application, Competitive Landscape, Key Strategies & Growth Prospect: Orbis Research

GlobeNewswire

Published

on

Reading Time: 3 minutes

Orbisresearch.com has published “Next-generation Sequencing (NGS)-Growth, Trends, and Forecast (2019-2024)” research study to its database. Genetic Screening is the Segment Expected to Grow Fastest During the Forecast Period

Dallas, Texas, Aug. 24, 2019 (GLOBE NEWSWIRE) — As per the scope of this report, NGS is a technology in which millions of DNA strands can be sequenced through massive parallelization; this technique is also known as high throughput sequencing. The low cost, high accuracy and speed, and precise results even from low sample input are the main advantages NGS offers over Sanger’s sequencing method. NGS is, therefore, being used to execute various applications, such as biomarker discovery, oncology studies, personalized medicine, and agricultural and animal research, among others. Thus, the NGS market has transformed the genomics and molecular diagnostics landscape.

The major factors, such as increasing applications of NGS, speed, cost, and accuracy, efficient replacement for traditional technologies, and drug discovery applications demanding NGS technology are expected to drive the growth of the overall market.

Request a sample@https://www.orbisresearch.com/contacts/request-sample/3585369

The rapid speed, cost, and accuracy of the NGS technology help in the growth of the market. This is attained with the help of modern DNA sequencing technology, which has contributed to the sequencing of complete DNA sequences of numerous types and species of life. It is also found that NGS is significantly cheaper, quicker, and needs significantly lesser DNA, which helps in the overall growth of the market.

The NGS has the potential to accelerate the early detection of disorders and the identification of pharmacogenetics markers to customize its treatments.

There are various technological advancements in the field of medicine that are growing at a rapid pace and has led to the development of personalized medicine. There are a huge number of applications of next-generation sequencing in personalized medicine. Thus, the development of personalized medicine has opened many avenues for the application of NGS, which could accelerate the market growth.

The current market is also facing challenges, owing to the difficulty in management of large data and complications, associated with Big Data management. In addition, some of the ethical issues associated with whole-genome sequencing, coupled with the lack of awareness among people, are pulling back the growth of the market.

Key Market Trends

Genetic Screening is the Segment Under Application that is Expected to Grow Fastest During the Forecast Period

In genetic screening, the NGS is highly useful in identifying monogenic diseases with locus heterogeneity, such as blindness, deafness, movement disorders, mitochondrial disease, hereditary cancers, etc. Therefore, NGS has a large number of varied applications through genetic screening in multiple disorders, but their affordability and availability in high-income and low-income countries may differ a lot. The entire genomes are being mapped at affordable costs. Thus, steady growth is expected in the forecast period.

The NGS is also emerging as a powerful promising pathogen-detection method for infectious-disease diagnostics. It helps in the identification and genomic characterization of bacteria, fungi, parasites, and viruses, without the need for prior knowledge of a specific pathogen, directly from clinical specimens. As the diseases caused by infections are increasing in the less-developed countries, the NGS-powered diagnosis of these infections has become the most promising method to detect these infectious diseases. The NGS also has applications in personalized medicine that has started becoming a reality and has been under application by various biotechnology companies.

Browse the full report@https://www.orbisresearch.com/reports/index/next-generation-sequencing-ngs-growth-trends-and-forecast-2019-2024

Asia-Pacific is the Fastest-growing Market and is Expected to Follow the Same Trend over the Forecast Period

The market studied is expected to grow at the fastest pace in Asia-Pacific. The rising focus of the major market players is on delivering advanced, efficient NGS technology to the developing countries, in order to cater to the need for genomic medicines and whole genome sequencing for personalized medicine. In addition, the increasing adoption of NGS technology by the non-government and government bodies, along with increased investment of the private players, is expected to drive the Asian market.

Competitive Landscape
There are major biotech industries that are making large investments on evolving preventive vaccines and therapeutic vaccines that can stop or cure diseases, varying from viruses to cancers. The biotech industry, thus, uses the NGS to develop advanced diagnostic kits, in order to screen for pathological conditions and infectious diseases.

Direct purchase a single user copy@https://www.orbisresearch.com/contact/purchase-single-user/3585369

Major points from Table of Contents:
1 INTRODUCTION
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
5 MARKET SEGMENTATION
6 COMPETITIVE LANDSCAPE
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
 Continued…

About Us:
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Contact Us:
Hector Costello
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +91 895 659 5155
Email ID: enquiry@orbisresearch.com   
Follow Us on Linkedin: https://www.linkedin.com/company/orbisresearch

Continue Reading

IT Industry

Cosmeceuticals Market to grow at 8.81% CAGR to hit $85 billion by 2024 – Global Insights on Emerging Trends, Product Type (Skin Care, Hair Care & Lip Care), Distribution Channel, Key Strategies & Growth Prospect: Orbis Research

GlobeNewswire

Published

on

Reading Time: 3 minutes

Orbisresearch.com has published “Cosmeceuticals Market-Growth, Trends and Forecasts (2019-2024)” research study to its database. Geographically, Asia-Pacific Dominates the Global Cosmeceuticals Market

Dallas, Texas, Aug. 24, 2019 (GLOBE NEWSWIRE) — Huge growth in necessary drugs to lessen the several skin problems and improve the appearance has increasingly supported the cosmeceuticals market growth since the past few years. Likewise, anti-ectoparasites and shampoos are the key cosmeceuticals products which are helping to increase consumer interest majorly in Europe and North America regions. In addition, rising demand for animal-friendly products is expected to contribute to the growth of the cosmeceuticals market over the forecast period.

The global cosmeceuticals market offers a wide range of products broadly categorised under skin care, hair care, lip care, and oral care. Also, the market covers the products available across distribution channels Supermarket/Hypermarkets, Convenience stores, online stores, speciality stores, others. Moreover, the study provides an analysis of the cosmeceuticals market in the emerging and established markets across the world, including North America, Europe, Asia-Pacific, South America, Middle East & Africa.

Request a sample@https://www.orbisresearch.com/contacts/request-sample/3586277

The global cosmeceuticals market is forecasted to reach USD 85 billion by 2024 growing at a CAGR of 8.81% during the forecast period (2019-2024).

– Countries, such as the United States, Canada, United Kingdom, Germany, and other European countries held a prominent share in the global cosmeceuticals market. China, India, and Vietnam present considerable growth opportunities for the market players, primarily due to the growing millennial population.
– Furthermore, raising awareness regarding cosmeceutical and cosmetics products, such as anti-aging, sun care, and hair care products, is expected to drive the growth potential in the near future. The introduction of new products with bio-active ingredients play a crucial role in driving the demand for cosmeceutical products across the world, especially in the Asia-Pacific region.

Key Market Trends

Growing Ageing Population
Consumers, especially the ageing population, are increasingly looking for methods and products to maintain and improve their appearance to look youthful and beautiful, more so with the rising awareness about anti-ageing products. The middle-aged people are increasingly witnessing ageing anxiety, due to the high prevalence of extrinsic signs of ageing. Anti-ageing skin products are known as cosmeceuticals, as they overlap the distinction between cosmetics and pharmaceuticals. Over the past two decades, declining fertility and mortality rate has resulted in a sustained rise in ageing population across the region, especially in China and Japan. Strong desire among men and women to retain youthful appearances has groomed and nurtured the cosmetic industry across the region.

Browse the full report@https://www.orbisresearch.com/reports/index/cosmeceutical-market-growth-trends-and-forecasts-2019-2024

Competitive Landscape
The most active companies in the market include key players, such as Procter & Gamble, Unilever, L’Oréal SA, Shiseido Co. Ltd, and The Estée Lauder Companies Inc. L’Oréal SA is one of the most active companies, with numerous brands offering a broad range of cosmeceuticals, across the world. The company has spent considerably on improving quality, product innovation in terms of ingredients, functionality, and packaging. Moreover, these active companies have adopted strategic acquisition as their key strategy, to increase their geographical presence and customer base.

Asia-Pacific Dominates the Global Cosmeceuticals Market
Though the term ‘cosmeceuticals’ started gaining momentum in China recently, it has now become one of the most preferred product categories in the country. Busier and stressful lifestyles of consumers in the country, as well as worsening environmental conditions, created more concern around skin conditions amid consumers who seek products for skin rejuvenation. This has led to an increase in sales of cosmeceuticals. Moreover, the population of Japan is among the most prolific consumers of cosmetics, placing it among the top five national markets for personal care products. From the viewpoint of not only size but also the trends and market demand, Japan can be regarded as a gateway to other Asian markets. Success in the Japanese market can raise product/brand profile and visibility, particularly in other Asian markets.

Direct purchase a single user copy@https://www.orbisresearch.com/contact/purchase-single-user/3586277

Major points from Table of Contents:
1 INTRODUCTION
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
5 MARKET SEGMENTATION
6 COMPETITIVE LANDSCAPE
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
 Continued…

About Us:
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Contact Us:
Hector Costello
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +91 895 659 5155
Email ID: enquiry@orbisresearch.com   
Follow Us on Linkedin: https://www.linkedin.com/company/orbisresearch

Continue Reading

IT Industry

Carrier Screening Market Global Insights on Test Type, Disease Type, Restraints, Competitive Landscape and 2019 Top Trends: Orbis Research

GlobeNewswire

Published

on

Reading Time: 4 minutes

Orbisresearch.com has published “Carrier Screening Market-Growth, Trends, and Forecast (2019-2024)” research study to its database.

Dallas, Texas, Aug. 24, 2019 (GLOBE NEWSWIRE) — The major factors for the growth of the carrier screening market include the increasing emphasis on early disease detection and prevention, rising demand for personalized medicine, and increasing application of screening tests in genetic disorders, which is expected to experience a boost during the forecast period.

The earlier a disease is diagnosed, the more likely it can be cured or successfully managed. Treating the disease early could also make the disease easier to live with. Early disease detection helps people plan ahead, while they are still able to make important decisions regarding their health and support needs and on financial and legal matters. Genetic diseases, such as cystic fibrosis, sickle cell anemia, and Tay-Sachs disease, are inherited disorders. Carrier testing for such diseases can provide information about a couple’s risk of having a child with a genetic condition. Identification of the risk, prior to the onset of symptoms, is called predictive/presymptomatic testing. Many genetic disorders can be detected early during pregnancy. So, the consumer demand for safe and effective carrier tests is fueling the growth of this market. In addition, the adoption of carrier tests into regular clinical care offers a commercial advantage to the market. According to many studies, early detection of diseases can prevent them completely or at least decrease the complications of the diseases. Healthcare organizations in several countries are funding newborn screening to predict diseases, like cancers, which may occur later in adulthood.

Request a sample@https://www.orbisresearch.com/contacts/request-sample/3585427

Scope of the Report

As per the scope of the report, carrier screening is a type of genetic test to identify the autosomal recessive genetic disorders, before or during a pregnancy stage. Further, it helps in identifying a child with a genetic disorder. The market is segmented on the basis of screening test type (molecular screening test/biochemical screening test), disease type (cystic fibrosis, Tay-Sachs disease, sickle cell disease, gaucher disease, spinal muscular atrophy, and other autosomal recessive genetic disorders). In developed countries, such as the United States, Germany, and France, among others, the demand for screening tests to detect the risk of genetic diseases is driving the market’s growth.

Browse the full report@https://www.orbisresearch.com/reports/index/carrier-screening-market-growth-trends-and-forecast-2019-2024

Key Market Trends

Molecular Screening Test Segment by Test Type is Expected to Register Fastest Growth Rate during the Forecast Period

A molecular screening test identifies DNA mutations, which are variations in the genetic code that lead to decreased production of enzymes. It focuses on the mutations seen in one ethnic group. It involves a step-wise process of testing for common alleles, and if required, extensive gene analysis. Sequencing is a method of molecular screening, which is accomplished by reading across the DNA code of a specific gene to know if there are any known mutations. If the test results are negative, it reduces the chances that the individual is a carrier, however, it does not eliminate the chance of having a carrier gene, since it is possible that the mutation might not have been discovered yet through the current technology.

Some of the prominent recessive disorders for which molecular testing is beneficial are Canavan disease, Cystic fibrosis, GM1 gangliosidosis, spinal muscular atrophy, etc. With advancements in genetic analysis tools, like assays based on next-generation sequencing and microarray technologies, molecular diagnostics are revolutionizing the practice of medicine, by improving the prenatal and reproductive care, enabling earlier disease detection, and advancing the treatment for heritable diseases. There is an expansion of molecular testing, as it has the potential to increase testing accuracies through technical benefits for many targeted disorders that may not be suggested to biochemical testing.

North America accounted for the Largest Share in the Global Market

North America is found to hold a major share of the carrier screening market and is expected to show a similar trend over the forecast period, without significant fluctuations. Genetic disease is the leading cause of infant deaths in the United States, accounting for approximately 20% of the total annual infant mortality. Many advances in genomic medicine and technological platforms have made possible low-cost, pan?ethnic, expanded carrier screening that enables obstetric care providers to offer screening for over 100 recessive genetic diseases. However, the rapid integration of this genomic medicine into the routine obstetric practice has raised some concerns about the practical implementation of carrier testing. According to the Cystic Fibrosis Foundation, more than 30,000 people suffer from cystic fibrosis in the United States, and approximately 1,000 new cases of cystic fibrosis are diagnosed each year in the country. Thus, as the prevalence of genetic diseases is increasing every year, the usage of carrier screening is also expected to increase during the forecast period.

Direct purchase a single user copy@https://www.orbisresearch.com/contact/purchase-single-user/3585427

Competitive Landscape

The presence of major market players, such as Abbott, F. Hoffmann-La Roche AG, Cepheid (Danaher Corporation), Illumina Inc., and Thermo Fisher Scientific Inc, in turn, is increasing the overall competitive rivalry of the market. Most of the market players are expanding their technologies through acquisitions and partnerships. For instance, in January 2017, Philips and Illumina collaborated to offer the integrated genomics solutions for oncology.

Major points from Table of Contents:
1 INTRODUCTION
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
5 MARKET SEGMENTATION
6 COMPETITIVE LANDSCAPE
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
 Continued…

About Us:
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Contact Us:
Hector Costello
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +91 895 659 5155
Email ID: enquiry@orbisresearch.com   
Follow Us on Linkedin: https://www.linkedin.com/company/orbisresearch

Continue Reading

Font Resizer

Subscribe to PICANTE via Email

Enter your email address to subscribe to PICANTE and receive notifications of new posts by email.

Follow us on Facebook

Read more from our authors

Business Wire36 mins ago

Federman & Sherwood Announces Filing of Securities Class Action Lawsuit Against Textron, Inc.

Business Wire36 mins ago

Federman & Sherwood Announces Filing of Securities Class Action Lawsuit Against Textron, Inc.

Business Wire2 hours ago

UBS Group AG and Merrill Lynch Are Being Investigated for Sales of Unsuitable Investments

IT Industry8 hours ago

Next-Generation Sequencing (NGS) Market 2019 Global Insights Type of Sequencing, Product Type, End User, Application, Competitive Landscape, Key Strategies & Growth Prospect: Orbis Research

IT Industry9 hours ago

Cosmeceuticals Market to grow at 8.81% CAGR to hit $85 billion by 2024 – Global Insights on Emerging Trends, Product Type (Skin Care, Hair Care & Lip Care), Distribution Channel, Key Strategies & Growth Prospect: Orbis Research

IT Industry10 hours ago

Carrier Screening Market Global Insights on Test Type, Disease Type, Restraints, Competitive Landscape and 2019 Top Trends: Orbis Research

IT Industry10 hours ago

Carrier Screening Market Global Insights on Test Type, Disease Type, Restraints, Competitive Landscape and 2019 Top Trends: Orbis Research

IT Industry10 hours ago

Influenza Diagnostics Market Estimated to grow at 6.83% to reach $731.97 Million by 2024- Global Insights on Test Type (Traditional Diagnostic Test and Molecular Diagnostic Assay), Restraints, Drivers and Future Trends: Orbis Research

Blockchain PR10 hours ago

Fantasy Sports Market Estimated to grow at 13.2% to reach $33200 Mn by 2025-Key Insights on Revenue (Value), Potential Application, Economic Fluctuations, Growth Rate and Future Trends: Orbis Research

Business Wire12 hours ago

FEDEX 72 HOUR DEADLINE ALERT: Approximately 72 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess Of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against FedEx Corporation

Follow our Tweets

Trending

Please turn AdBlock off